APLT

APLT

USD

Applied Therapeutics Inc. Common Stock

$0.365+0.000 (0.000%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$0.365

Haut

$0.385

Bas

$0.360

Volume

1.09M

Fondamentaux de l'Entreprise

Capitalisation Boursière

51.7M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

2.18M

Bourse

NGM

Devise

USD

Intervalle sur 52 Semaines

Bas $0.295Actuel $0.365Haut $10.624

Actualités Connexes

GlobeNewswire

Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

Slowing of progression of disease observed via MRI at 24 months Improvements in outcomes and reduction in sorbitol maintained through 24 months Statistically significant correlation between absolute reduction in

Voir plus
Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
Analyst Upgrades

RBC Capital Reiterates Sector Perform on Applied Therapeutics, Maintains $1.5 Price Target

RBC Capital analyst Brian Abrahams reiterates Applied Therapeutics with a Sector Perform and maintains $1.5 price target.

Voir plus
RBC Capital Reiterates Sector Perform on Applied Therapeutics, Maintains $1.5 Price Target

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.